Enzomac Forte Tablet is a pharmaceutical formulation combining Bromelain (180 mg), Trypsin (96 mg), and Rutoside (200 mg), designed to provide potent anti-inflammatory, proteolytic, and vascular protective effects. Bromelain, a proteolytic enzyme derived from pineapple stems, facilitates the breakdown of proteins, thereby reducing inflammation and edema in various inflammatory conditions. Trypsin, a serine protease enzyme, complements this action by promoting the degradation of fibrin and other necrotic tissues, enhancing tissue repair and accelerating wound healing. Rutoside, a bioflavonoid, exhibits strong antioxidant properties and strengthens capillary walls, reducing capillary permeability and fragility, which is beneficial in managing vascular disorders and preventing hemorrhagic complications. The synergistic combination of these active ingredients makes Enzomac Forte effective in the management of acute and chronic inflammatory conditions such as post-traumatic edema, postoperative swelling, and inflammatory vascular diseases. It is also indicated in the treatment of phlebitis and thrombophlebitis due to its fibrinolytic and anti-edematous properties. Enzomac Forte should be administered under medical supervision, considering contraindications such as hypersensitivity to any component, bleeding disorders, or concurrent anticoagulant therapy. Overall, Enzomac Forte offers a comprehensive approach to inflammation control and vascular protection, improving patient outcomes in inflammatory and vascular pathologies.